DE60329237D1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number: DE60329237D1
Authority: DE; Germany
Prior art keywords: linezolid; crystalline form; preparation; relates; present
Prior art date: 2003-10-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60329237T

Other languages

English (en)

Inventor

Rao Dodda Mohan

Reddy Pingili Krishna

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Symed Labs Ltd

Original Assignee

Symed Labs Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-16

Filing date

2003-10-16

Publication date

2009-10-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60329237(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-16 Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd

2009-10-22 Application granted granted Critical

2009-10-22 Publication of DE60329237D1 publication Critical patent/DE60329237D1/de

2023-10-17 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Photoreceptors In Electrophotography (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DE60329237T 2003-10-16 2003-10-16 Kristalline form von linezolid Expired - Lifetime DE60329237D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000336 WO2005035530A1 (en)	2003-10-16	2003-10-16	A novel crystalline form of linezolid

Publications (1)

Publication Number	Publication Date
DE60329237D1 true DE60329237D1 (de)	2009-10-22

Family

ID=34430675

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60329237T Expired - Lifetime DE60329237D1 (de)	2003-10-16	2003-10-16	Kristalline form von linezolid
DE2009163348 Pending DE09163348T1 (de)	2003-10-16	2003-10-16	Kristalline Form von Linezolid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE2009163348 Pending DE09163348T1 (de)	2003-10-16	2003-10-16	Kristalline Form von Linezolid

Country Status (10)

Country	Link
US (4)	US7714128B2 (de)
EP (3)	EP2100884A1 (de)
AT (1)	ATE442364T1 (de)
AU (1)	AU2003278592A1 (de)
DE (2)	DE60329237D1 (de)
DK (1)	DK1673370T3 (de)
ES (3)	ES2331001T3 (de)
HU (1)	HUE051230T2 (de)
PT (1)	PT1673370E (de)
WO (1)	WO2005035530A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2331001T3 (es)	2003-10-16	2009-12-18	Symed Labs Limited	Forma cristalina de linezolid.
EP1737850B1 (de)	2004-04-19	2007-10-03	Symed Labs Limited	Neues verfahren zur herstlelung von linezolid und verwandten verbindungen
CA2572054A1 (en) *	2004-06-29	2006-01-12	Teva Pharmaceutical Industries Ltd.	Crystalline form iv of linezolid
EP1745028A2 (de) *	2004-06-29	2007-01-24	Teva Pharmaceutical Industries Ltd	Linezolid in fester form und herstellungsverfahren dafür
WO2006091731A2 (en) *	2005-02-24	2006-08-31	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of linezolid intermediate
DK1749517T3 (da) *	2005-07-20	2008-11-03	Teva Pharma	Stabil farmaceutiske sammensætning af linezolid form IV
IT1390957B1 (it) *	2008-07-07	2011-10-27	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
EP2033960A3 (de)	2007-09-04	2009-04-29	Dipharma Francis S.r.l.	Kristalline Linezolidhydratform und Linezolidsalze
US20090093631A1 (en) *	2007-09-06	2009-04-09	Ben-Zion Dolitzky	Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) *	2008-05-14	2009-11-19	Dr. Reddy's Laboratories Ltd.	Linezolid co-crystals
WO2011050826A1 (en)	2009-10-28	2011-05-05	Synthon B.V.	Process for making crystalline form a of linezolid
EP2493867A1 (de)	2009-10-28	2012-09-05	Synthon BV	Verfahren zur herstellung einer kristallinen form von linezolid
EP2516408A1 (de)	2009-12-26	2012-10-31	Alembic Pharmaceuticals Limited	Verfahren zur herstellung von linezolid
WO2012019632A1 (en)	2010-08-11	2012-02-16	Synthon B.V.	Process for making linezolid
EP2690100A1 (de)	2010-08-11	2014-01-29	Synhton B.V.	Verfahren zur Linezpolid Herstellung
WO2012029074A2 (en)	2010-09-02	2012-03-08	Hetero Research Foundation	Pharmaceutical compositions of linezolid
CN102070548B (zh) *	2011-01-13	2012-12-26	浙江新东港药业股份有限公司	一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
CN103402990A (zh)	2011-02-24	2013-11-20	李药业有限公司	无水利奈唑胺晶型-ii
EP2683696A1 (de)	2011-03-09	2014-01-15	Synthon BV	Verfahren zur herstellung einer kristallinen form von linezolid
CN105461648B (zh) *	2011-05-03	2018-01-12	江苏豪森药业集团有限公司	利奈唑胺的晶型及其制备方法
ITMI20111311A1 (it) *	2011-07-14	2013-01-15	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en)	2011-09-19	2013-05-23	Cadila Healthcare Limited	Process for the preparation of crystalline linezolid
WO2013093751A1 (en) *	2011-12-24	2013-06-27	Alembic Pharmaceuticals Limited	Packaging for linezolid
IN2014DN06213A (de) *	2012-01-24	2015-10-23	Jubilant Life Sciences Ltd
WO2013120496A1 (en)	2012-02-14	2013-08-22	Pharmathen S.A.	Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) *	2012-06-19	2013-12-27	Symed Labs Limited	Improved processes for the preparation of linezolid crystalline form iii
WO2014033744A2 (en)	2012-08-10	2014-03-06	Indoco Remedies Limited	A novel pharmaceutical composition of linezolid
ES2603252T3 (es)	2012-11-09	2017-02-24	Synthon Bv	Proceso para preparar linezolid
WO2014118809A1 (en)	2013-01-29	2014-08-07	Actavis Group Ptc Ehf.	Pharmaceutical composition with linezolid
WO2015068121A1 (en)	2013-11-06	2015-05-14	Unimark Remedies Ltd.	Process for preparation of crystalline form i of linezolid and its compositions
CN105254580B (zh) *	2014-04-22	2018-01-02	江苏豪森药业集团有限公司	利奈唑胺晶型的制备方法
IN2015CH00214A (de) *	2015-01-13	2015-04-24	Nosch Labs Private Ltd
WO2018051360A1 (en) *	2016-09-16	2018-03-22	Lee Pharma Limited	A novel process for the preparation of crystalline linezolid form-iii
EP3541442B1 (de)	2016-11-16	2022-01-19	Persica Pharmaceuticals Ltd.	Antibiotische formulierungen für rückenschmerzen im unteren rückenbereich
KR102787942B1 (ko)	2017-11-16	2025-03-31	페르시카 파마슈티컬스 리미티드	리네졸리드 제제
CN110194750A (zh) *	2019-06-19	2019-09-03	四川美大康华康药业有限公司	一种利奈唑胺的制备方法及精制方法
JP2024537142A (ja)	2021-10-12	2024-10-10	ペルシカファーマシューティカルズリミテッド	腰痛治療

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US583870A (en) *		1897-06-01		Wrench
DE2810349A1 (de)	1978-03-10	1979-09-20	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr)	1978-06-09	1982-12-03	Delalande Sa	Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en)	1980-10-23	1982-07-20	E. I. Du Pont De Nemours And Company	3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr)	1986-12-19	1989-04-28	Delalande Sa	Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
DE9310451U1 (de)	1993-03-05	1994-06-30	Landis & Gyr Business Support Ag, Zug	Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
DE59306401D1 (de)	1993-03-11	1997-06-12	Landis & Gyr Tech Innovat	Brennerregler
MY115155A (en) *	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en)	1994-08-16	1997-11-18	Pharmacia & Upjohn Company	Substituted oxazine and thiazine oxazolidinone antimicrobials
PT1114819E (pt)	1996-04-11	2008-02-28	Pharmacia & Upjohn Co Llc	Processo para preparação de oxazolidinonas
EP0890791A1 (de)	1997-07-11	1999-01-13	Electrowatt Technology Innovation AG	Steuer- und Regelgerät für einen Brenner
HUP0004388A3 (en) *	1997-11-07	2001-10-29	Upjohn Co	Process for the preparation of oxazolidinones, intermediates and preparation thereof
US6444813B2 (en)	2000-02-02	2002-09-03	Pharmacia & Upjohn Company	Linezolid-crystal form II
AR027261A1 (es)	2000-02-02	2003-03-19	Upjohn Co	Linezolid forma cristalina ii
MY127336A (en)	2000-03-22	2006-11-30	Upjohn Co	Container for linezolid iv solution
DE10037585A1 (de) *	2000-08-02	2002-02-14	Valeo Schalter & Sensoren Gmbh	Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
ES2310410T3 (es)	2000-08-14	2009-01-01	Teva Pharmaceutical Industries Ltd.	Preparacion de risperidona.
US20030008012A1 (en) *	2001-02-05	2003-01-09	Pena Lorraine E.	Composition for rectal delivery of an oxazolidinone antibacterial drug
ATE374463T1 (de) *	2001-04-20	2007-10-15	Pharmacia & Upjohn Co Llc	Verfahren zur herstellung von oxazolidinonen
CN1155585C (zh)	2001-12-19	2004-06-30	中国医学科学院医药生物技术研究所	3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en)	2002-08-09	2006-01-31	Cephalon France	Modafinil polymorphic forms
ES2331001T3 (es)	2003-10-16	2009-12-18	Symed Labs Limited	Forma cristalina de linezolid.
EP1737850B1 (de)	2004-04-19	2007-10-03	Symed Labs Limited	Neues verfahren zur herstlelung von linezolid und verwandten verbindungen
CA2572054A1 (en)	2004-06-29	2006-01-12	Teva Pharmaceutical Industries Ltd.	Crystalline form iv of linezolid
ES2325401T3 (es)	2004-07-20	2009-09-03	Symed Labs Limited	Intermedios novedosos para linezolid y compuestos relacionados.

2003
- 2003-10-16 ES ES03769887T patent/ES2331001T3/es not_active Expired - Lifetime
- 2003-10-16 AT AT03769887T patent/ATE442364T1/de active
- 2003-10-16 HU HUE15155714A patent/HUE051230T2/hu unknown
- 2003-10-16 ES ES15155714T patent/ES2803516T3/es not_active Expired - Lifetime
- 2003-10-16 EP EP20090163348 patent/EP2100884A1/de not_active Withdrawn
- 2003-10-16 DK DK03769887T patent/DK1673370T3/da active
- 2003-10-16 WO PCT/IN2003/000336 patent/WO2005035530A1/en active Application Filing
- 2003-10-16 US US10/524,478 patent/US7714128B2/en not_active Expired - Lifetime
- 2003-10-16 DE DE60329237T patent/DE60329237D1/de not_active Expired - Lifetime
- 2003-10-16 PT PT03769887T patent/PT1673370E/pt unknown
- 2003-10-16 DE DE2009163348 patent/DE09163348T1/de active Pending
- 2003-10-16 EP EP03769887A patent/EP1673370B1/de not_active Revoked
- 2003-10-16 ES ES09163348T patent/ES2331454T1/es active Pending
- 2003-10-16 EP EP15155714.7A patent/EP2902386B1/de not_active Expired - Lifetime
- 2003-10-16 AU AU2003278592A patent/AU2003278592A1/en not_active Abandoned
2007
- 2007-09-26 US US11/861,433 patent/US7718800B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,406 patent/US7732597B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,340 patent/US7718799B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20080091011A1 (en)	2008-04-17
US20080090824A1 (en)	2008-04-17
ES2331454T1 (es)	2010-01-05
ES2803516T3 (es)	2021-01-27
AU2003278592A1 (en)	2005-04-27
PT1673370E (pt)	2009-11-05
US20080090820A1 (en)	2008-04-17
US20060128703A1 (en)	2006-06-15
US7732597B2 (en)	2010-06-08
US7718799B2 (en)	2010-05-18
US7714128B2 (en)	2010-05-11
US7718800B2 (en)	2010-05-18
ES2331001T3 (es)	2009-12-18
EP2100884A1 (de)	2009-09-16
EP2902386A1 (de)	2015-08-05
WO2005035530A1 (en)	2005-04-21
ATE442364T1 (de)	2009-09-15
EP1673370B1 (de)	2009-09-09
DK1673370T3 (da)	2009-12-07
DE09163348T1 (de)	2010-01-07
HUE051230T2 (hu)	2021-03-01
EP2902386B1 (de)	2020-04-08
EP1673370A1 (de)	2006-06-28

Publication	Publication Date	Title
DE60329237D1 (de)	2009-10-22	Kristalline form von linezolid
DE60315368D1 (de)	2007-09-20	Korrektur des Weissabgleichs
EP1633307A4 (de)	2009-06-24	Modulation der survivin-expression
CO5611137A2 (es)	2006-02-28	Composiciones de clorhidrato de naltrexona
ATE372767T1 (de)	2007-09-15	Dpp-iv-hemmer
NO20071642L (no)	2007-06-01	N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
CY2013036I2 (el)	2015-12-09	Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DE60238917D1 (de)	2011-02-24	Modifikation des ölprofils von pflanzen
DE60333020D1 (de)	2010-07-29	Anzeigeeinrichtung des dünnen typs
ATE428701T1 (de)	2009-05-15	Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
ZA200309887B (en)	2004-07-20	Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
NO20050132D0 (no)	2005-01-11	Vaksinesammensetning
DK1255754T3 (da)	2005-08-22	Linezolid-krystalform II
DE60201084D1 (de)	2004-09-30	Herstellung von cyclischen esteroligomeren
HRP20080057T3 (en)	2008-02-29	9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
IL166483A0 (en)	2006-01-15	Pharmaceutical compositions containing ciclesonideand an antihistamine
DE50213650D1 (de)	2009-08-13	Einrichtung zur Herstellung von Stapelpaketen
ATE527280T1 (de)	2011-10-15	Fluoreszentprotein und chromoprotein
DK1644385T3 (da)	2008-01-02	Siliciumforbindelser og deres anvendelse
DE602004030779D1 (de)	2011-02-10	Angehen des problems des schrittmachersyndroms
ATE474824T1 (de)	2010-08-15	Herstellung von olefinen
DE60307022D1 (de)	2006-09-07	Herstellung von Organohalosilanen
DK1648906T3 (da)	2008-02-04	Organo-silicium-forbindelser og deres anvendelse
ATE328595T1 (de)	2006-06-15	Carvedilolpolymorph
DE50100533D1 (de)	2003-09-25	Herstellung von 2-ethyl-3-methyl-1,4-diazin

Legal Events

Date	Code	Title	Description
2010-06-10	8363	Opposition against the patent
2012-02-08	R082	Change of representative	Ref document number: 1673370 Country of ref document: EP Representative=s name: LEDERER & KELLER, 80538 MUENCHEN, DE

Date

Code

Title

Description

2010-06-10

8363

Opposition against the patent

2012-02-08

R082

Change of representative

Ref document number: 1673370

Country of ref document: EP

Representative=s name: LEDERER & KELLER, 80538 MUENCHEN, DE